GW PHARMA FINALLY STARTS MOVE UP ON POTENTIAL SATIVEX NEWS

GW pharma (GWP), developer of the Sativex cannabis spray for pain and spasticity in multiple sclerosis, has finally started moving up. After a 6% rise yesterday, the stock rose 5% today.  Rumours are rife that approval for Sativex by the European regulatory body is close. Contrarian Investor UK, awaits tomorrow with interest as GWP is the portfolio's largest holding and is now showing a healthy profit. But I have no intention of selling before approval when I expect a 35%+ share price rise.

Hilary Clinton offers to help on Falklands Islands oil dispute

Hillary Clinton said on Monday that she plans to meet Argentinian President, Cristina Fernandez de Kirchner, was ready to help Argentina and Britain resolve the dispute over the Falkland Islands. Clinton said "It is our position that this is a matter to be resolved between the United Kingdom and Argentina. If we can be of any help in facilitating such an effort, we stand ready to do so."

Micron Technology snaps up 7% on SanDisk results

On Friday, SanDisk (SNDK) raised its forecast for the March quarter and made positive noises about the memory chip market in general. Today, the stock was up nearly 12% to $32.63.

This was seen as good news for sector stocks. A broker note yesterday from Lazard Capital raised revenue and profit forecasts for Micron’s second quarter which ends in February on the basis of solid NAND and DRAM chip demand. Revenue forecast was increased to $1.848 billion from $1.820 billion and EPS forecast increases 7 cents to 30 cents. For 2010, Lazard believes Micron Technology should produce revenues of $7.49 billion and EPS of $1.06 a share, from $7.42 billion and 98 cents.The stock has a $18 target, and is currently $9.7, implying a 100% upside.

Given much DRAM chip demand is created by PC sales, the outlook for stocks such as Microsoft and Hewlett Packard looks strong.